UCO Bank (UCOBANK.BO)
INR 45.25
(-0.26%)
INR 45.25
(-0.26%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 113.65 Billion | 98.51 Billion | 95.73 Billion | 89.24 Billion | 79.7 Billion | 54.29 Billion |
| Cost of Revenue | -137.54 Billion | - | - | - | - | - |
| Gross Profit | 251.19 Billion | 98.51 Billion | 95.73 Billion | 89.24 Billion | 79.7 Billion | 54.29 Billion |
| Operating Expenses | 113.65 Billion | 55.1 Billion | 47.76 Billion | 47.54 Billion | 55.42 Billion | 46.62 Billion |
| Selling, General and Administrative Expenses | 591.3 Million | 536.72 Million | 472.51 Million | 556.07 Million | 550.75 Million | 573.73 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 113.06 Billion | -14.01 Billion | -12.82 Billion | -11.67 Billion | -10.47 Billion | -9.72 Billion |
| Cost and Expenses | 113.65 Billion | 177.57 Billion | 166.45 Billion | 182.41 Billion | 217.18 Billion | 229.08 Billion |
| Operating Income | 25.73 Billion | 34.51 Billion | 17.61 Billion | 364.8 Million | -34.69 Billion | -68.24 Billion |
| Interest Expense | 137.53 Billion | 103.07 Billion | 85.08 Billion | 89.66 Billion | 100.42 Billion | 100.19 Billion |
| Income Tax Expense | 9.15 Billion | 10.42 Billion | 8.2 Billion | -2.42 Billion | -12.75 Billion | -27.43 Billion |
| Earnings before Tax | 25.68 Billion | 18.62 Billion | 9.29 Billion | 1.45 Billion | -37.12 Billion | -70.64 Billion |
| Net Income | 16.71 Billion | 18.26 Billion | 9.29 Billion | 1.45 Billion | -24.36 Billion | -43.21 Billion |
| Earnings Per Share Basic | 1.40 | 1.53 | 0.77 | 0.17 | -2.83 | -5.01 |
| Earnings Per Share Diluted | 1.40 | 1.53 | 0.77 | 0.17 | -2.83 | -5.01 |
| Weighted Average Shares Outstanding | 11.95 Billion | 11.95 Billion | 11.63 Billion | 9.91 Billion | 8.62 Billion | 8.62 Billion |
| Weighted Average Shares Outstanding (Diluted) | 11.95 Billion | 11.95 Billion | 11.63 Billion | 9.91 Billion | 8.62 Billion | 8.62 Billion |
| Gross Margin | 2.21 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | 0.37 | 0.20 | 0.02 | -0.42 | -1.23 |
| Profit Margin | 0.15 | 0.19 | 0.10 | 0.02 | -0.31 | -0.80 |
| EBITDA | - | 31.6 Billion | 19.15 Billion | 589.3 Million | -35.75 Billion | -69.27 Billion |
| Earnings Before Tax Margin | 0.23 | 0.35 | 0.18 | 0.00 | -0.44 | -1.26 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 32.93 Billion | 68.59 Billion | 69.84 Billion | 251.19 Billion | 28.48 Billion | 25.63 Billion |
| Cost of Revenue | -37.78 Billion | - | - | - | - | - |
| Gross Profit | 70.71 Billion | 68.59 Billion | 69.84 Billion | 251.19 Billion | 28.48 Billion | 25.63 Billion |
| Operating Expenses | 18.61 Billion | 5.59 Billion | 4.96 Billion | 19.03 Billion | 17.29 Billion | 15.81 Billion |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 18.61 Billion | -5.59 Billion | -4.96 Billion | -19.03 Billion | -4.76 Billion | -5.19 Billion |
| Cost and Expenses | 61.32 Billion | 59.96 Billion | 61.79 Billion | 225.51 Billion | 56.35 Billion | 52.25 Billion |
| Operating Income | 9.38 Billion | 43.4 Million | 64.87 Billion | 232.16 Billion | 7.79 Billion | 6.41 Billion |
| Interest Expense | 37.78 Billion | 37.7 Billion | 36.72 Billion | 137.53 Billion | 35.63 Billion | 33.02 Billion |
| Income Tax Expense | 3.36 Billion | 3.11 Billion | 2.79 Billion | 9.15 Billion | 2.74 Billion | 2.38 Billion |
| Earnings before Tax | 9.38 Billion | 8.62 Billion | 8.05 Billion | 25.68 Billion | 7.76 Billion | 6.39 Billion |
| Net Income | 6.06 Billion | 5.55 Billion | 5.37 Billion | 16.71 Billion | 5.05 Billion | 4.03 Billion |
| Earnings Per Share Basic | 0.51 | 0.46 | 0.44 | - | 0.42 | 0.34 |
| Earnings Per Share Diluted | 0.51 | 0.46 | 0.44 | - | 0.42 | 0.34 |
| Weighted Average Shares Outstanding | 11.89 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion |
| Weighted Average Shares Outstanding (Diluted) | 11.89 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion |
| Gross Margin | 2.15 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 0.29 | 0.00 | 0.00 | - | 0.27 | 0.25 |
| Profit Margin | 0.18 | 0.08 | 0.08 | 0.07 | 0.18 | 0.16 |
| EBITDA | 9.38 Billion | 43.4 Million | 120.76 Million | - | 7.79 Billion | 6.41 Billion |
| Earnings Before Tax Margin | 0.29 | 0.00 | 0.93 | 0.92 | 0.27 | 0.25 |
4513
3325
AIDX
1541
UFCS
TRMED